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Objectives: The effect of glucose and palmitate on the phosphoryla-
tion of proteins associated with cell growth and survival (extracellular
signalYregulated kinase 1/2 [ERK1/2] and stress-activated protein
kinase/c-Jun NH2-terminal kinase [SAPK/JNK]) and on the expression
of immediate early genes was investigated.
Methods: Groups of freshly isolated rat pancreatic islets were
incubated in 10-mmol/L glucose with palmitate, LY294002, or
fumonisin B1 for the measurement of the phosphorylation and the
content of ERK1/2, JNK/SAPK, and v-akt murine thymoma viral
oncongene (AKT) (serine 473) by immunoblotting. The expressions of
the immediate early genes, c-fos and c-jun, were evaluated by reverse
transcription-polymerase chain reaction.
Results: Glucose at 10 mmol/L induced ERK1/2 and AKT phosphor-
ylations and decreased SAPK/JNK phosphorylation. Palmitate (0.1
mmol/L) abolished the glucose effect on ERK1/2, AKT, and SAPK/JNK
phosphorylations. LY294002 caused a similar effect. The inhibitory
effect of palmitate on glucose-induced ERK1/2 and AKT phosphory-
lation changes was not observed in the presence of fumonisin B1.
Glucose increased c-fos and decreased c-jun expressions. Palmitate and
LY294002 abolished these latter glucose effects. The presence of
fumonisin B1 abolished the effect induced by palmitate on c-jun
expression.
Conclusions: Our results suggest that short-term changes of mitogen-
activated protein kinase and AKT signaling pathways and c-fos and c-jun
expressions caused by glucose are abolished by palmitate through
phosphatidylinositol 3-kinase inhibition via ceramide synthesis.
Key Words: pancreatic islets, glucose, palmitate, ERK1/2, SAPK/JNK,
ceramide
(Pancreas 2009;38: 585Y592)
Impairments of the response to glucose and/or alterations in thesurvival of pancreatic A cell are implicated in the onset of type 2
diabetes (DM2). This condition is associated with peripheral
insulin resistance, but diabetes is clinically established only after
the impairment of insulin secretory function and the decrease
of A-cell mass.1 Phosphatidylinositol 3-kinase (PI3K) and
mitogen-activated protein kinase (MAPK) pathways regulate
pancreatic A-cell insulin secretion, growth, and cell survival.2,3
We have recently shown that short-term PI3K/AKT/protein
kinase C X/L modulation is involved in glucose- and palmitate-
induced insulin secretion.4 Other proteins from the MAPK
family, such as p42 and p44 (ERK1/2) and p46 and p54 (SAPK/
JNK) MAPKs, also modulate the insulin secretion.5Y7 However,
the most important role of ERK1/2 and SAPK/JNK for
pancreatic A cell is the regulation of proliferation, cell growth,
and survival.8,9
Extracellular signalYregulated kinase 1/2 regulates gene
expression, mitosis, and cell differentiation,8 whereas activation
of SAPK/JNK has been described to cause cell death through
apoptosis.9 Nutrients such as glucose and free fatty acids (FFAs),
anticipatory hormones, insulin, and growth factors raise the
expression of ERK1/2 in pancreatic A cells.10 In turn, SAPK/
JNK is stimulated by several exogenous and endogenous stress-
inducing stimuli including reactive oxygen species, proinflam-
matory cytokines, and hyperglycemia and high FFA levels.11 In
addition, signaling events triggered by glucose and FFA also
result in a rapid and transient MAPK-induced activation of
immediate early genes (IEGs), including c-fos and c-jun.12,13
The levels of IEGs in A cells react and rapidly change in
response to metabolic signals and transcription factors and
regulate, in turn, the transcription of downstream target genes.
The importance of such indirect mechanism has recently been
shown in genome-scaled studies.14,15 Both IEGs and target
codes for protein are involved in a large spectrum of cellular
functions and long-term cellular adaptations.15 An important
actor in this scenario is the activator protein 1 transcription factor
that binds to DNA as a dimer composed by fos and jun gene
products and regulates the transcription of several secondary
genes including insulin gene.16,17
Prolonged exposure to elevated levels of palmitate affects
glucose-stimulated insulin gene expression, long-term insulin
secretion, and cellular replication by mechanisms that involve
ceramide synthesis.18,19 This sphingolipid is classically reported
as a molecule that controls antiproliferative responses such as
apoptosis, growth arrest, cell differentiation, and senescence.20
We have recently shown that short-term PI3K activation
regulated by ceramide is involved in glucose- and palmitate-
induced insulin secretion.4 Although the consequences of long-
term administration of ceramide on MAPK cascade have been
investigated,21 the short-time effect of ceramide on pancreatic
islet MAPK-regulated functions remains to be investigated. In
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the present study, the effect of glucose and palmitate in up to a
1-hour exposure on the phosphorylation state of ERK1/2 and
SAPK/JNK and the expressions of c-fos and c-jun was
examined. The association of the effects induced by glucose
and/or palmitate with ceramide synthesis was also investigated.
MATERIALS AND METHODS
Reagents
The reagents for protein assay (BioRad Protein Assay-Dye
Reagent Concentrate), the apparatus for sodium dodecyl
sulfateYpolyacrylamide gel electrophoresis (SDS-PAGE), and
the immunoblotting and nitrocellulose paper (0.45 Km) were
obtained from Bio-Rad (Melville, NY). Trizma, aprotinin,
dithiothreitol, phenylmethylsulfonyl fluoride, Triton X-100,
glycerol, Tween 20, sodium palmitate, collagenase type V, and
bovine serum albumin (fraction V) were obtained from Sigma
Chemical Co (St Louis, Mo). Immunoblot-enhanced chemilu-
minescence detection kit was purchased from Amersham
Biosciences/GE Healthcare (Buckinghamshire, UK).
The antibodies against phosphotyrosine; phospho-AKT1/2/3
(serine 473 [Ser473]); and total insulin receptor (IR), IR substrate
1 (IRS1), IRS2, AKT1, and AKT2 were purchased from Santa
Cruz Biotechnology (Santa Cruz, Calif). The antibodies against
phospho-ERK1/2, phospho-SAPK/JNK, and total ERK1/2 and
the PI3K inhibitor LY294002 were acquired from Cell
Signaling Technology, Inc (Beverly, Mass). Trizol, SuperScript
II (200 U), MgCl2, dNTPs, and Taq DNA polymerase were
from Invitrogen (Carlsbad, Calif). The band intensity was
measured in a UVP Bio-imaging System equipped with
LabWork image acquisition and software analysis from UVP
Inc (Upland, Calif ).
Animals
Female albino rats weighing 250 to 350 g were obtained
from the Institute of Biomedical Sciences (University of Sa˜o
Paulo). The animals were kept under standard lighting
conditions (12-hour light-dark cycle, lights on at 7:00 A.M.) at
23 T 1-C, in groups of 5, and were allowed free access to
standard rodent chow and water. The study was approved by the
Ethical Committee of the Institute of Biomedical Sciences, Sao
Paulo University.
Isolation of Pancreatic Islets
Islets were isolated by collagenase digestion of the exocrine
pancreas after a method previously described.22 Hanks buffer
containing 137-mmol/L NaCl, 5-mmol/L KCl, 1-mmol/L CaCl2,
1-mmol/L MgSO4 7H2O, 0.3-mmol/L Na2HPO4, 0.4-mmol/L
KH2PO4, and 4-mmol/L NaHCO3 was used for isolation and
pooling the islets.
Incubation of Pancreatic Islets
Groups of 200 to 300 freshly isolated islets were initially
incubated for 30 minutes at 37-C in 0.5 mL of Krebs bicarbonate
buffer (KB; 460-mmol/L NaCl, 96-mmol/L NaHCO3, 20-mmol/L
KCl, 4-mmol/L MgCl2, and 4-mmol/L CaCl2) with 0.2%
albumin. The buffer was equilibrated in a mixture of 95/5%
(O2/CO2), and pH was adjusted to 7.4. This solution was replaced,
and islets were maintained for different periods in KB containing
5.6- or 10-mmol/L glucose, 10-mmol/L glucose plus 0.1-mmol/L
palmitate, 10-mmol/L glucose plus 50-Kmol/L LY294002
(a PI3K inhibitor), or 10-mmol/L glucose plus 15-Kmol/L
fumonisin B1 (a ceramide synthase inhibitor). Before addition,
palmitate was dissolved in ethanol to form an emulsified fatty acid
solution. The final ethanol concentration in the incubation
medium was always lower than 0.5%. Preliminary experiments
established that this ethanol concentration has no effect on basal
insulin release.23 In experiments with LY294002 and fumonisin
B1, the islets were preincubated and postincubated in the absence
or presence of the inhibitors as described in the figure legends.
The inhibitors were dissolved in dimethyl sulfoxide before
addition to the incubation medium. The final dimethyl sulfoxide
concentration in the medium was lower than 0.1%, and this
concentration was also used in control conditions (5.6- and 10-
mmol/L glucose).
At the end of the experiments, the KB was removed, and 80
to 100 KL of extraction buffer (100-mmol/L Trizma, 10% SDS,
10-mmol/L sodium pyrophosphate, 100-mmol/L sodium fluo-
ride, 10-mmol/L EDTA, and 10-mmol/L sodium vanadate) was
added. The islets were then sonicated and boiled for 10 minutes.
The extracts were then centrifuged at 12,000g at 4-C for 20
minutes to remove cellular debris. The protein of the
supernatant was determined by the Bradford dye method using
the Bio-Rad reagent.
Protein Electrophoresis and Immunoblotting
Equal amounts of proteins from the samples were added to
Laemmli buffer (1:5) and boiled for 10 minutes before loading
the SDS-polyacrylamide gel. The electrotransfer of proteins
from the gel to nitrocellulose was performed for 1 to 2 hours at
120 Vusing a Bio-Rad miniature transfer apparatus. Nonspecific
protein binding to nitrocellulose was reduced by preincubating
the membrane for 2 hours at 22-C in blocking buffer (5% non-fat
dry milk, 10-mmol/LTris, 150-mmol/L NaCl, and 0.02% Tween
20). The nitrocellulose membranes were incubated for 4 hours at
22-C or overnight at 4-C, with antibodies against phosphotyr-
osine, IR, IRS1, IRS2, phospho-AKT1/2/3 (Ser473), phospho-
ERK1/2, phospho-SAPK/JNK, AKT1, AKT2, or ERK1/2
diluted in blocking buffer replaced by 3% of non-fat dry milk,
and then washed for 30 minutes in blocking buffer without
milk. The blots were subsequently incubated with peroxidase-
conjugated secondary antibody for 1 hour and processed for
enhanced chemiluminescence to visualize the immunoreactive
bands. When necessary, the membranes were stripped, washed,
and reprobed with different primary antibodies. Band intensi-
ties were quantified by optical densitometry (Scion Image-
Release Beta 3b; National Institutes of Health, Bethesda, Md)
of the developed autoradiograph.
Isolation of Total RNA
Total RNAwas extracted from fresh islets, using the Trizol
reagent (Invitrogen) as described in the product protocol. RNA
was spectrophotometrically determined by measuring absor-
bance at 260 nm. The integrity of the RNA samples was
evaluated in 2% (wt/vol) agarose gel containing ethidium
bromide and visualized with ultraviolet transillumination.
Reverse Transcriptase<Polymerase Chain Reaction
The RNA used for reverse transcriptase<polymerase chain
reaction (RT-PCR) analysis was obtained from 3 independent
experiments. The RT-PCR was performed with 1 to 2 Kg of total
RNA of each experimental condition using Moloney murine
leukemia virus reverse transcriptase (Superscript II) and random
hexanucleotide primers. The complementary DNA was diluted
in a 1:2 ratio, and 1 KL was used for RT-PCR. The assays were
performed in quadruplicate with recombinant Taq DNA
polymerase and 10 pmol of each primer in a master mix of
100 KL. Gene-specific primers were designed according to
GenBank sequences encoding c-fos (X06769), c-jun (X17163),
rpl37a (X14069), and A-actin (NM_031144). The primers used
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for the RT-PCR analysis with their respective melting points and
product lengths were as follows:
c-fos, 5¶-CCCTGCCTCTTCTCAATGACCC-3¶ (sense) and
5¶-CAGCTTGGTGTGTTTCACGCAC-3¶ (antisense), 60.4-C,
556 bp;
c-jun, 5¶-TACGACGATGCCCTCAACGC-3¶ (sense) and
5¶-GTGATGTGCCCATTGCTGGAC-3¶ (antisense), 59.9-C,
239 bp;
rpl37a, 5¶-CAAGAAGGTCGGGATCGTCG-3¶ (sense) and
5¶-ACCAGGCAAGTCTCAGGAGGTG-3¶ (antisense), 57.5-C,
290 bp; and
A-actin, 5¶-ATGAAGATCCTGACCGAGCGTG-3¶ (sense) and
5¶-CTTGCTGATCCACATCTGCTGG-3¶ (antisense), 58.5-C, 510 bp.
For each gene, the number of cycleswaswithin the logarithmic
phase of amplification and defined through standard curves with
20 to 42 cycles. Polymerase chain reaction productswere separated
on 1.2% ethidium bromide-agarose gels, and the intensities of the
bandswere determined by digital scanning and quantified by using
Scion Image analysis software (Scion Corp). The results were
expressed as a ratio of target gene to rpl37a or A-actin signal.
Statistical Analysis
Results are presented as mean (SEM). Significant differ-
ences between groups were analyzed by using analysis of
variance followed by the Tukey post test. The level of sig-
nificance was set at P G 0.05.
RESULTS
Temporal ERK1/2, SAPK/JNK, and AKT
Phosphorylations Induced by Glucose
The temporal analysis of ERK1/2 (Fig. 1A) and SAPK/
JNK (Fig. 1B) phosphorylations induced by glucose revealed a
40% increase and a 26% decrease, respectively, after a 5-minute
incubation. This period of glucose exposure was then adopted
there on to investigate the combined effect of palmitate with
glucose (10 mmol/L). To investigate the mechanism by which
glucose changed ERK1/2 and SAPK/JNK phosphorylations,
temporal AKT phosphorylation induced by 10-mmol/L glucose
was also analyzed. The temporal analysis showed that the
maximum increasing effect of glucose on threonine AKT
phosphorylation occurred after 1.5 minutes of the stimulus and
returned to the unstimulated level at 5 minutes (data not shown).
Serine AKT phosphorylation was detected 1.5 minutes after the
stimulus and remained increased up to 5minutes of the stimulation
(Fig. 1C). Based on these results, the experiments performed to
evaluate the effect of palmitate on glucose-induced phosphoryla-
tion of serine AKTwere carried out in incubations for 5 minutes.
Palmitate Abolished the Effect of Glucose on AKT
Phosphorylation
Palmitate abolished the effect of glucose (10 mmol/L) on
ERK1/2 and SAPK/JNK phosphorylations. The values observed
for the combination of palmitate with glucose (10 mmol/L) were
FIGURE 1. Time-course response of ERK1/2 (A), SAPK/JNK (B), and AKT (Ser473) phosphorylations (C). Groups of 200 to 300 freshly
isolated islets were preincubated for 30 minutes at 37-C in Krebs-Henseleit buffer with 5.6-mmol/L glucose. This solution was then
replaced, and islets were maintained for 1.5, 5, 15, 30, 45, or 60 minutes in Krebs-Henseleit buffer containing 10-mmol/L glucose.
Protein (100 Kg) extracts from homogenized islets were resolved in SDS-PAGE, transferred to nitrocellulose membranes, and blotted (IB)
with specific antibodies. Scanning densitometry was performed on autoradiograms from independent experiments. The results are
expressed as mean (SEM). A: pERK1/2: n = 6; ERK1/2: n = 3; B: pSAPK/JNK: n = 4; SAPK/JNK: n = 3; C: pAKT (Ser473): n = 4; AKT1: n = 3;
AKT2: n = 3; *P G 0.05 versus control islets (CTL). CTL indicates control; IB, immunoblotting; pAKT, phospho-AKT; pERK1/2,
phospho-ERK1/2; pSAPK/JNK, phospho-SAPK/JNK. The same abbreviations are used in Figures 2Y5.
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similar to that reported for islets incubated with only 5.6-mmol/L
glucose (Figs. 2A and B, respectively). Indeed, incubation of
isolated pancreatic islets with palmitate completely abolished the
effect of 10-mmol/L glucose on serine AKT phosphorylation
(Fig. 2C).
Phosphatidylinositol 3-Kinase Inhibition
Mimicked the Effect of Palmitate on
Glucose-Induced Changes in AKT, ERK1/2,
and SAPK/JNK Phosphorylations
The PI3K inhibitor LY294002 was used to confirm the
participation of PI3K in the effect of palmitate on the changes of
AKT, ERK1/2, and SAPK/JNK phosphorylations induced by
glucose. As observed for palmitate, LY294002 abolished
glucose-induced AKT and ERK1/2 phosphorylations (Figs. 3A
and C, respectively). Glucose inhibition of SAPK/JNK phosphor-
ylation was also abolished by LY294002 treatment (Fig. 3B).
Palmitate Modulated Glucose Effects on AKT,
ERK1/2, and SAPK/JNK Phosphorylations Possibly
via Ceramide Synthesis
Palmitate raises the intracellular levels of ceramide by increas-
ing its synthesis.24 Increased de novo synthesis of ceramide inhibits
PI3K/AKT pathway in insulin-responsive cells.25Y27 Fumonisin B1
(a ceramide synthase inhibitor) was used to evaluate whether the
effect of palmitate on glucose-induced changes of ERK1/2, AKT,
and SAPK/JNK pathways could be a result of ceramide generation
resulting in PI3K inhibition. Fumonisin B1 (15 Kmol/L) com-
pletely inhibited the effect of palmitate on AKT (Ser473), ERK1/2,
and SAPK/JNK phosphorylations (Figs. 4AYC). Under the block-
ade of ceramide synthesis, palmitate was no longer able to alter the
glucose effect on the signaling pathway downstream to PI3K.
Palmitate Abolished Glucose-Induced Changes
of c-fos and c-jun Expressions
The expressions of c-fos and c-jun genes are regulated by
the MAPK signaling cascade.28 Short-term exposure (30
minutes) of isolated pancreatic islets to 10-mmol/L glucose
caused an increase of 40% in c-fos expression (Fig. 5A) and a
decrease of 32% in c-jun expression (Fig. 5B). The addition of
palmitate and LY294002 abolished the effect of glucose on c-fos
and c-jun expressions. The treatment of pancreatic islets with
fumonisin B1 abolished the effect induced by palmitate on c-jun
but not on c-fos expression.
DISCUSSION
High plasma levels of glucose and fatty acids lead pancreatic
A-cell to death and so the establishment of diabetes. Short-term
FIGURE 2. Effect of palmitate on glucose-induced phosphorylation of ERK1/2 (A), SAPK/JNK (B), and AKT (Ser473; C) in rat pancreatic
islets. Groups of 200 to 300 freshly isolated islets were preincubated for 30 minutes at 37-C in Krebs-Henseleit 5.6-mmol/L glucose.
This solution was then replaced, and islets were maintained for 5 minutes in Krebs-Henseleit containing 5.6-mmol/L and 10-mmol/L
glucose or 10-mmol/L glucose plus 0.1-mmol/L palmitate. Protein (100 Kg) extracts from homogenized islets were resolved in
SDS-PAGE, transferred to nitrocellulose membranes and blotted (IB) with specific antibody. Scanning densitometry was performed
on autoradiograms from independent experiments. The results are expressed as mean (SEM). A: pERK1/2: n = 6; ERK1/2: n = 3;
B: pSAPK/JNK: n = 4; SAPK/JNK: n = 3; C: pAKT (Ser473): n = 7; AKT1: n = 3; AKT2: n = 3; *P G 0.05 versus islets exposed to G5.6 or
**P G 0.05 versus islets exposed to G10.
Nogueira et al Pancreas & Volume 38, Number 5, July 2009
588 | www.pancreasjournal.com * 2009 Lippincott Williams & Wilkins
9Copyright @ 200  Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
exposure of the pancreatic A cells to high glucose and palmitate
concentrations results in a substantial increase of insulin release.
However, prolonged exposure of pancreatic A cells to high levels of
FFA (924 hours) increases insulin secretion at low glucose level and
leads to desensitization and suppression of the secretory response
stimulated by glucose.29 Data obtained in rodent and human
pancreatic islets and in A-cell lines indicate that FFAs, in particular,
palmitic acid, also decrease A-cell number, essentially by accel-
erating cell death. Evidence has been accumulated indicating that
loss of A cells may also occur in DM2. Studies report a decreased
A-cell mass and increased apoptosis in autopsies of the pancreas
from patients with DM2 compared with appropriate controls.30
Stress-activated protein kinase/JunN-terminal kinase cascade
plays an important role in the initiation of apoptosis, whereas ERK
cascade promotes cell proliferation and/or differentiation.31
Accordingly, the balance between SAPK and ERK activation
has been proposed as the key determinant of cell survival.32 In this
study, the short-term effect (up to 1 hour) of glucose and palmitate
on ERK1/2 and SAPK/JNK phosphorylations was investigated.
In agreement with previous studies,33,34 high glucose levels
increased ERK1/2 phosphorylation. However, in contrast to
studies that evaluated the effect of palmitate on insulin-induced
phosphorylation of ERK1/2,35,36 this fatty acid decreased
glucose-induced ERK1/2 phosphorylation.37
High glucose concentration may induce oxidative stress and
activation of the proteins of the stress signaling pathway in several
tissues, including the pancreas.38,39 However, in opposition to the
effect on ERK1/2, glucose at 10 mmol/L decreased SAPK/JNK
phosphorylation. As also observed by others,40,41 we showed that
palmitate increased SAPK/JNK activity.
AKT (also known as serine/threonine protein kinase B) is a
key mediator of signal transduction processes associated with cell
survival.42 AKT may suppress the JNK pathway and apoptotic
signal in pancreatic islets.43 AKT can indeed regulate the
acting of several proteins to suppress the JNK pathway, such as
mixed-lineage kinase 3,44 JNK-interacting protein 1,45 and
mitogen-activated protein kinase kinase 4.46 In particular, AKT
phosphorylates apoptosis signalYregulating kinase 1, leading to
the suppression of JNK signaling.45 We have recently shown that
glucose and palmitate induced short-term regulation of PI3K/AKT
phosphorylation.4 We then explored the possibility of an AKT-
SAPK/JNK crosstalk to occur in islets after treatment with glucose
and palmitate. In fact, some authors have demonstrated a temporal
and inverse correlation between activation of AKTand SAPK after
islet isolation.43 Incubation with glucose significantly increased
serineAKTphosphorylation. The curves of glucose effect onAKT
and SAPK/JNK phosphorylations indicate an opposite correlation
between these two proteins. Palmitate addition abolished the
FIGURE 3. Effect of PI3K inhibitors (LY294002) on glucose-induced changes of ERK1/2, SAPK/JNK and AKT (Ser473) phosphorylation.
Groups of 200 to 300 freshly islets were preincubated in the absence or presence of LY294002. The islets were then incubated for
5 minutes in Krebs-Henseleit buffer containing 5.6-mmol/L and 10-mmol/L glucose and 10-mmol/L glucose plus LY294002. Total protein
extracts from homogenized islets were separated by SDS-PAGE, transferred to nitrocellulose membranes, and blotted (IB) with pAKT
(Ser473), pERK1/2, and pSAPK/JNK antibodies. Scanning densitometry was performed on autoradiograms from independent
experiments. The results are expressed as mean (SEM). A: pERK1/2: n = 3; ERK1/2: n = 3; pSAPK/JNK: n = 3; SAPK/JNK: n = 3; pAKT
(Ser473): n = 3; AKT1: n = 3, AKT2: n = 3; *P G 0.05 versus islets exposed to G5.6 or **P G 0.05 versus islets exposed to G10.
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glucose effects on AKT phosphorylation. A similar observation
was reported by us and others in pancreatic islets and other
tissues.4,26
Glucose-induced changes of ERK1/2, SAPK/JNK, and AKT
phosphorylations could be mediated by an autocrine/paracrine
effect on insulin release. However, no alteration of IR and IRS1/2
phosphorylation was observed after incubation of pancreatic
islets with glucose or glucose plus palmitate for 30 minutes or
1.5 hours (data not shown). Thus, we next evaluated if the effect
of glucose on the phosphorylation state of ERK1/2, SAPK/JNK,
and AKTwas directly associated with PI3K activation, using an
inhibitor of this enzyme. LY294002 significantly inhibited the
increase of AKT (Ser473) and ERK1/2 phosphorylations
induced by glucose. The decrease of SAPK/JNK phosphoryla-
tion induced by glucose was also abolished in the presence of
LY294002. These observations suggest that activation or
inhibition of these proteins is IR and IRS1/2 independent but
PI3K dependent.
The mechanism involved in the effect of glucose on PI3K
activation, leading to an increase of AKT and consequently a
decrease in SAPK/JNK activity, is not still known. On the other
hand, ERK1/2 activation may be directly or indirectly dependent
on PI3K.47,48
Ceramides are natural membrane sphingolipids and have
been regarded as important second messengers in signaling
pathways that regulate several cell functions. Ceramide modu-
lation of apoptosis involves hydrolysis of sphingomyelin or de
novo synthesis. Serine/threonine protein kinases, serine/threo-
nine protein phosphatases, and protein kinase C X are targets of
ceramide. Ceramide formation regulates PI3K activation and,
consequently, ERK1/2, SAPK/JNK, and AKT activity.49
Palmitate is a substrate for de novo ceramide synthesis, which
involves condensation of palmitoyl-CoA with L-serine by serine
palmitoyltransferase.50 In turn, high glucose levels increase
palmitoyl-CoA formation in pancreatic A cell and lead to insulin
secretion.51We have shown that ceramide formation is involved in
the modulation of insulin secretion by glucose and palmitate.4
Herein, the effect of glucose and palmitate on the activity of
signal proteins under a blockage of ceramide synthesis was
investigated. The augmentation of ERK1/2 and AKT (Ser473)
FIGURE 4. Effect of ceramide synthesis blockage (by fumonisin B1) on changes of AKT (Ser473), ERK1/2, and SAPK/JNK phosphorylations
in islets of rats. Groups of 200 to 300 fresh islets were preincubated in the absence or presence of fumonisin B1. The islets were then
incubated for 5 minutes in Krebs-Henseleit buffer containing 5.6-mmol/L and 10-mmol/L glucose and 10-mmol/L glucose plus
fumonisin B1. Total protein extracts from homogenized islets were separated by SDS-PAGE, transferred to nitrocellulose membranes,
and blotted (IB) with pAKT (Ser473), pERK1/2, and pSAPK/JNK antibodies. Scanning densitometry was performed on autoradiograms
from independent experiments. The results are expressed as mean (SEM) [pERK1/2: n = 4, ERK1/2: n = 3; pSAPK/JNK: n = 3, SAPK/JNK:
n = 3; pAKT (Ser473): n = 4; AKT1: n = 3, AKT2: n = 3; *P G 0.05 versus islets exposed to G5.6, **P G 0.05 versus islets exposed to G10,
or #P G 0.05 versus islets exposed to G10P].
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phosphorylations and the reduction of SAPK/JNK phosphoryla-
tion induced by glucose were abolished by palmitate. Treatment
with fumonisin B1 (an inhibitor of ceramide synthesis) abolished
the effect induced by palmitate. Therefore, the effect of palmitate
was possibly mediated by ceramide formation.
The expression of genes associated with metabolism, cell
cycle, and apoptosis is also regulated by glucose and FFAs.52,53
These nutrients modulate the expression of IEGs that are involved
in the regulation of cell growth and differentiation. Expression of
the IEGs c-fos and c-jun is regulated by the MAPK signaling
cascade.28 In the present study, glucose caused a significant
increase of c-fos expression but a decreased c-jun expression.
Palmitate and LY294002 abolished these effects. Other studies,
however, showed that glucose induces an increase in the
expression of both c-fos and c-jun in pancreatic tumoral A cell
and other cell types, but FFAs induce an increase in the
expression of both genes.54,55 These discrepancies might occur
because of differences between cell lines and pancreatic islets
and concentrations of palmitate and/or glucose in the medium.
Indeed, incubation with fumonisin B1 slightly abolished the
effect induced by palmitate on c-fos possibly because of the
period of incubation.15 However, fumonisin B1 was able to
abolish the effect induced by palmitate on c-jun gene expression.
In summary, our results have shown the short-time effect (up
to 30minutes) of glucose onAKTandMAPKpathways and on c-
fos and c-jun expressions in rat pancreatic islets. These effects
were abolished by palmitate treatment and could be a
consequence of a PI3K inhibition through intracellular accumu-
lation of ceramide. These findings suggest a crosstalk and a
balance between the MAPK and PI3K/AKT signaling cascades
in the regulation of pancreatic A-cell growth and survival.
Glucose (at 10 mmol/L) raised pancreatic A-cell survival,
whereas palmitate caused an opposite effect. Alterations in the
synthesis of early genes such as c-fos and c-jun, which then
regulate late genes such as GLUT-2, PEPCK, and insulin, may
also represent an important mechanism involved in the effect of
glucose and palmitate on pancreatic A-cell function.
Changes in the MAPK protein activity induced by short
exposure to glucose and/or FFA, via ceramide synthesis, may
compromise growth and survival of pancreatic A cells that may
lead to failure of pancreatic islet function and DM2 later on.
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